ATE252903T1 - Arzneimittel zur behandlung konvulsivischer zustände - Google Patents

Arzneimittel zur behandlung konvulsivischer zustände

Info

Publication number
ATE252903T1
ATE252903T1 AT00985589T AT00985589T ATE252903T1 AT E252903 T1 ATE252903 T1 AT E252903T1 AT 00985589 T AT00985589 T AT 00985589T AT 00985589 T AT00985589 T AT 00985589T AT E252903 T1 ATE252903 T1 AT E252903T1
Authority
AT
Austria
Prior art keywords
treatment
medicinal products
convulsive conditions
convulsive
conditions
Prior art date
Application number
AT00985589T
Other languages
English (en)
Inventor
Elizabeth Janina Davidson
Fiona Craig
Original Assignee
Celltech Pharma Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929981.0A external-priority patent/GB9929981D0/en
Priority claimed from GB0019061A external-priority patent/GB0019061D0/en
Application filed by Celltech Pharma Europ Ltd filed Critical Celltech Pharma Europ Ltd
Application granted granted Critical
Publication of ATE252903T1 publication Critical patent/ATE252903T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
AT00985589T 1999-12-17 2000-12-15 Arzneimittel zur behandlung konvulsivischer zustände ATE252903T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9929981.0A GB9929981D0 (en) 1999-12-17 1999-12-17 The treatment of convulsive states
GB0019061A GB0019061D0 (en) 2000-08-03 2000-08-03 The treatment of convulsive states
PCT/GB2000/004838 WO2001043730A2 (en) 1999-12-17 2000-12-15 The treatment of convulsive states

Publications (1)

Publication Number Publication Date
ATE252903T1 true ATE252903T1 (de) 2003-11-15

Family

ID=26244786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985589T ATE252903T1 (de) 1999-12-17 2000-12-15 Arzneimittel zur behandlung konvulsivischer zustände

Country Status (7)

Country Link
US (1) US7384959B2 (de)
EP (1) EP1239858B1 (de)
AT (1) ATE252903T1 (de)
AU (1) AU2199901A (de)
DE (1) DE60006284T2 (de)
ES (1) ES2210025T3 (de)
WO (1) WO2001043730A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
CA2420569A1 (en) * 2000-08-28 2002-03-07 Mel H. Epstein Use of threo-methylphenidate compounds to enhance memory
US20110200663A1 (en) * 2010-02-12 2011-08-18 Nitto Denko Corporation Methylphenidate patch preparation
WO2014203696A1 (ja) * 2013-06-20 2014-12-24 国立大学法人 岡山大学 抗てんかん薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9805870A (de) * 1996-01-22 1999-01-31
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Also Published As

Publication number Publication date
DE60006284T2 (de) 2004-07-29
EP1239858A2 (de) 2002-09-18
US7384959B2 (en) 2008-06-10
WO2001043730A2 (en) 2001-06-21
EP1239858B1 (de) 2003-10-29
WO2001043730A3 (en) 2002-06-13
ES2210025T3 (es) 2004-07-01
AU2199901A (en) 2001-06-25
US20030162810A1 (en) 2003-08-28
DE60006284D1 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
AU7031500A (en) Therapeutic quinazoline compounds
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
MY138883A (en) Use of asiatic acid for treatment of cencer
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE60042984D1 (de) Arzneitmittel zur Behandlung von Duchenne-Muskeldystrophie
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
EP1251126A3 (de) Fluor-substituierte benzensulfonyl-derivate zur behandlung von entzündungen
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
GB0020504D0 (en) Therapeutic method
GB9907571D0 (en) Compounds
ATE252903T1 (de) Arzneimittel zur behandlung konvulsivischer zustände
ATE289196T1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
AU2001233955A1 (en) Diagnosis and treatment of bipolar affective disorder
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
SE0004827D0 (sv) Therapeutic compounds
PL355113A1 (en) Novel fusidic acid derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties